The Trump administration's negotiated agreement with Eli Lilly and Novo Nordisk regarding obesity medication pricing and coverage is encountering implementation problems. The deal, which was intended to expand access to GLP-1 medications while controlling costs, contains unspecified loopholes or structural issues affecting its execution. The problems impact how these high-cost medications are covered and reimbursed under federal health programs. Medicaid managed care organizations should monitor whether state programs adjust coverage policies or capitation rates in response to these federal-level complications.
Why it mattersGLP-1 medications represent one of the fastest-growing pharmacy cost drivers for Medicaid MCOs, and any federal pricing or coverage framework directly affects plan formularies, prior authorization protocols, and budget forecasting.
Pharmacy · Managed Care · Finance
The Government Accountability Office identified one additional priority recommendation for the Social Security Administration in June 2026, bringing the total to four open priority recommendations. SSA has not implemented any of the three recommendations GAO identified in May 2025. The priority areas include preventing potential overpayments in Disability Insurance, improving online application access for Social Security benefits, and managing IT investments cost-effectively. GAO emphasizes these recommendations warrant urgent attention from SSA leadership to strengthen internal controls, improve service delivery, and identify opportunities for efficiency and cost savings.
Why it mattersMedicaid managed care organizations with dual-eligible members or integrated care arrangements need visibility into SSA operations because SSA disability determinations affect Medicaid eligibility and coordination of benefits for dual-eligible populations.
The Office of the National Coordinator for Health Information Technology (ONC) has awarded a new contract to oversee the Trusted Exchange Framework and Common Agreement (TEFCA), the federal framework governing nationwide health information exchange. The move comes as the volume of health records exchanged through TEFCA increases significantly. The new oversight contractor will monitor compliance with TEFCA's technical and legal requirements for data sharing among qualified health information networks. This expansion of oversight signals federal emphasis on ensuring secure, standardized data exchange as TEFCA adoption accelerates.
Why it mattersMedicaid MCOs must comply with TEFCA data sharing requirements when exchanging member health information, and expanded federal oversight may lead to stricter enforcement of technical standards and data use agreements that affect MCO health information exchange infrastructure and vendor relationships.
Managed Care